Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Velcade, Doxil, and Dexamethasone (VDd) as First Line Therapy for Multiple Myeloma

This study has been completed.
Information provided by:
University of Michigan Cancer Center Identifier:
First received: June 30, 2005
Last updated: February 5, 2012
Last verified: February 2012
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2007
  Primary Completion Date: January 2007 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by Identifier (NCT Number):